Kyverna Therapeutics Inc. (KYTX)
Kyverna Therapeutics Statistics
Share Statistics
Kyverna Therapeutics has 43.22M shares outstanding. The number of shares has increased by 0.23% in one year.
| 43.22M |
| 0.23% |
| 0.1% |
| 66.01% |
| n/a |
| 2,252 |
| 0.73% |
Short Selling Information
The latest short interest is 2.58M, so 5.97% of the outstanding shares have been sold short.
| 2.58M |
| 5.97% |
| 10.39% |
| 11.4 |
Valuation Ratios
The PE ratio is -1.12 and the forward PE ratio is -0.91. Kyverna Therapeutics's PEG ratio is 0.
| -1.12 |
| -0.91 |
| 0 |
| 0.9 |
| 0.54 |
| -1.23 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Kyverna Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 8.61, with a Debt / Equity ratio of 0.03.
| 8.61 |
| 8.61 |
| 0.03 |
| -0.06 |
| -0.07 |
| -1004.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,138,187.5 |
| 112 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -78.29% in the last 52 weeks. The beta is 2.54, so Kyverna Therapeutics's price volatility has been higher than the market average.
| 2.54 |
| -78.29% |
| 2.21 |
| 3.98 |
| 65.56 |
| 309,190 |
Balance Sheet
The company has 96.62M in cash and 8.24M in debt, giving a net cash position of 88.38M.
| 96.62M |
| 8.24M |
| 88.38M |
| -263.52M |
| 260.65M |
| 214.36M |
Cash Flow
In the last 12 months, operating cash flow was -114.25M and capital expenditures -2.21M, giving a free cash flow of -116.45M.
| -114.25M |
| -2.21M |
| -116.45M |
| -3.04 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
KYTX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for KYTX is $20, which is 580.3% higher than the current price. The consensus rating is "Buy".
| $20 |
| 580.3% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -0.69 |
| 1 |